Cargando…

Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways

Background: Pulmonary fibrosis (PF) is a chronic, progressive, and, ultimately, terminal interstitial disease caused by a variety of factors, ranging from genetics, bacterial, and viral infections, to drugs and other influences. Varying degrees of PF and its rapid progress have been widely reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yifei, Zhang, Yihan, Pan, Zhenyu, Yang, Chao, Chen, Lin, Wang, Yuanyuan, Xu, Dengfeng, Xia, Hui, Wang, Shaokang, Chen, Shiqing, Hao, Yoong Jun, Sun, Guiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912851/
https://www.ncbi.nlm.nih.gov/pubmed/35268069
http://dx.doi.org/10.3390/nu14051094
_version_ 1784667264337838080
author Lu, Yifei
Zhang, Yihan
Pan, Zhenyu
Yang, Chao
Chen, Lin
Wang, Yuanyuan
Xu, Dengfeng
Xia, Hui
Wang, Shaokang
Chen, Shiqing
Hao, Yoong Jun
Sun, Guiju
author_facet Lu, Yifei
Zhang, Yihan
Pan, Zhenyu
Yang, Chao
Chen, Lin
Wang, Yuanyuan
Xu, Dengfeng
Xia, Hui
Wang, Shaokang
Chen, Shiqing
Hao, Yoong Jun
Sun, Guiju
author_sort Lu, Yifei
collection PubMed
description Background: Pulmonary fibrosis (PF) is a chronic, progressive, and, ultimately, terminal interstitial disease caused by a variety of factors, ranging from genetics, bacterial, and viral infections, to drugs and other influences. Varying degrees of PF and its rapid progress have been widely reported in post-COVID-19 patients and there is consequently an urgent need to develop an appropriate, cost-effective approach for the prevention and management of PF. Aim: The potential “therapeutic” effect of the tocotrienol-rich fraction (TRF) and carotene against bleomycin (BLM)-induced lung fibrosis was investigated in rats via the modulation of TGF-β/Smad, PI3K/Akt/mTOR, and NF-κB signaling pathways. Design/Methods: Lung fibrosis was induced in Sprague-Dawley rats by a single intratracheal BLM (5 mg/kg) injection. These rats were subsequently treated with TRF (50, 100, and 200 mg/kg body wt/day), carotene (10 mg/kg body wt/day), or a combination of TRF (200 mg/kg body wt/day) and carotene (10 mg/kg body wt/day) for 28 days by gavage administration. A group of normal rats was provided with saline as a substitute for BLM as the control. Lung function and biochemical, histopathological, and molecular alterations were studied in the lung tissues. Results: Both the TRF and carotene treatments were found to significantly restore the BLM-induced alterations in anti-inflammatory and antioxidant functions. The treatments appeared to show pneumoprotective effects through the upregulation of antioxidant status, downregulation of MMP-7 and inflammatory cytokine expressions, and reduction in collagen accumulation (hydroxyproline). We demonstrated that TRF and carotene ameliorate BLM-induced lung injuries through the inhibition of apoptosis, the induction of TGF-β1/Smad, PI3K/Akt/mTOR, and NF-κB signaling pathways. Furthermore, the increased expression levels were shown to be significantly and dose-dependently downregulated by TRF (50, 100, and 200 mg/kg body wt/day) treatment in high probability. The histopathological findings further confirmed that the TRF and carotene treatments had significantly attenuated the BLM-induced lung injury in rats. Conclusion: The results of this study clearly indicate the ability of TRF and carotene to restore the antioxidant system and to inhibit proinflammatory cytokines. These findings, thus, revealed the potential of TRF and carotene as preventive candidates for the treatment of PF in the future.
format Online
Article
Text
id pubmed-8912851
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89128512022-03-11 Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways Lu, Yifei Zhang, Yihan Pan, Zhenyu Yang, Chao Chen, Lin Wang, Yuanyuan Xu, Dengfeng Xia, Hui Wang, Shaokang Chen, Shiqing Hao, Yoong Jun Sun, Guiju Nutrients Article Background: Pulmonary fibrosis (PF) is a chronic, progressive, and, ultimately, terminal interstitial disease caused by a variety of factors, ranging from genetics, bacterial, and viral infections, to drugs and other influences. Varying degrees of PF and its rapid progress have been widely reported in post-COVID-19 patients and there is consequently an urgent need to develop an appropriate, cost-effective approach for the prevention and management of PF. Aim: The potential “therapeutic” effect of the tocotrienol-rich fraction (TRF) and carotene against bleomycin (BLM)-induced lung fibrosis was investigated in rats via the modulation of TGF-β/Smad, PI3K/Akt/mTOR, and NF-κB signaling pathways. Design/Methods: Lung fibrosis was induced in Sprague-Dawley rats by a single intratracheal BLM (5 mg/kg) injection. These rats were subsequently treated with TRF (50, 100, and 200 mg/kg body wt/day), carotene (10 mg/kg body wt/day), or a combination of TRF (200 mg/kg body wt/day) and carotene (10 mg/kg body wt/day) for 28 days by gavage administration. A group of normal rats was provided with saline as a substitute for BLM as the control. Lung function and biochemical, histopathological, and molecular alterations were studied in the lung tissues. Results: Both the TRF and carotene treatments were found to significantly restore the BLM-induced alterations in anti-inflammatory and antioxidant functions. The treatments appeared to show pneumoprotective effects through the upregulation of antioxidant status, downregulation of MMP-7 and inflammatory cytokine expressions, and reduction in collagen accumulation (hydroxyproline). We demonstrated that TRF and carotene ameliorate BLM-induced lung injuries through the inhibition of apoptosis, the induction of TGF-β1/Smad, PI3K/Akt/mTOR, and NF-κB signaling pathways. Furthermore, the increased expression levels were shown to be significantly and dose-dependently downregulated by TRF (50, 100, and 200 mg/kg body wt/day) treatment in high probability. The histopathological findings further confirmed that the TRF and carotene treatments had significantly attenuated the BLM-induced lung injury in rats. Conclusion: The results of this study clearly indicate the ability of TRF and carotene to restore the antioxidant system and to inhibit proinflammatory cytokines. These findings, thus, revealed the potential of TRF and carotene as preventive candidates for the treatment of PF in the future. MDPI 2022-03-05 /pmc/articles/PMC8912851/ /pubmed/35268069 http://dx.doi.org/10.3390/nu14051094 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lu, Yifei
Zhang, Yihan
Pan, Zhenyu
Yang, Chao
Chen, Lin
Wang, Yuanyuan
Xu, Dengfeng
Xia, Hui
Wang, Shaokang
Chen, Shiqing
Hao, Yoong Jun
Sun, Guiju
Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways
title Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways
title_full Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways
title_fullStr Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways
title_full_unstemmed Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways
title_short Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways
title_sort potential “therapeutic” effects of tocotrienol-rich fraction (trf) and carotene “against” bleomycin-induced pulmonary fibrosis in rats via tgf-β/smad, pi3k/akt/mtor and nf-κb signaling pathways
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912851/
https://www.ncbi.nlm.nih.gov/pubmed/35268069
http://dx.doi.org/10.3390/nu14051094
work_keys_str_mv AT luyifei potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT zhangyihan potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT panzhenyu potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT yangchao potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT chenlin potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT wangyuanyuan potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT xudengfeng potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT xiahui potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT wangshaokang potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT chenshiqing potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT haoyoongjun potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways
AT sunguiju potentialtherapeuticeffectsoftocotrienolrichfractiontrfandcaroteneagainstbleomycininducedpulmonaryfibrosisinratsviatgfbsmadpi3kaktmtorandnfkbsignalingpathways